CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-16 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2022-08-16 | Parlavecchio Caryn CHRO | Shares withheld for taxes | −1,401 | $11.34 | $16K | 78,649 |
| 2022-07-08 | Gilman Michael Director | Gift | −37,459 | 0 | ||
| 2022-07-08 | Gilman Michael Director | Gift | +37,459 | 37,459 | ||
| 2022-06-22 | Nashat Amir Director | Purchase | +1,131,850 | $4.90 | $5.5M | 3,540,530 |
| 2022-06-22 | Nashat Amir Director | Purchase | +66,142 | $4.90 | $324K | 206,897 |
| 2022-06-22 | Nashat Amir Director | Purchase · Common Warrant (right to buy) | +282,962 | $4.90 | $1.4M | 282,962 |
| 2022-06-22 | Nashat Amir Director | Purchase · Common Warrant (right to buy) | +16,536 | $4.90 | $81K | 16,536 |
| 2022-06-16 | Vaishnaw Akshay Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-06-16 | Parlavecchio Caryn CHRO | Grant or award | +35,750 | 80,050 | ||
| 2022-06-16 | Parlavecchio Caryn CHRO | Grant or award · Stock Option (Right to Buy) | +35,750 | 35,750 | ||
| 2022-06-16 | Myles Edward H COO & CFO | Grant or award | +74,750 | 154,222 | ||
| 2022-06-16 | Myles Edward H COO & CFO | Grant or award · Stock Option (Right to Buy) | +74,750 | 74,750 | ||
| 2022-06-16 | Mahanthappa Nagesh K. Interim CEO and President | Grant or award | +50,000 | 480,491 | ||
| 2022-06-16 | Mahanthappa Nagesh K. Interim CEO and President | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-16 | Ho Junlin General Counsel | Grant or award | +45,500 | 120,591 | ||
| 2022-06-16 | Ho Junlin General Counsel | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2022-06-16 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-06-16 | Gilman Michael Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-06-16 | Carven Gregory John Chief Scientific Officer | Grant or award | +45,500 | 128,208 |
Page 21 of 22 · 422 trades